Table 3. Clinical conditions ofT2DM patients attending public hospitals in Harari region, Eastern Ethiopia, February to March2019 (n = 374).

Variables	Categories	Frequency	Percentage
Duration of diabetes (in years)	< 5	196	52.4
	≥ 5	178	47.6
Medications taken for diabetes	Metformin	210	56.1
	Metformin and glibenclamide	136	36.4
	Insulin	55	14.7
Medications taken for diseases other than diabetes	Yes	170	45.5
	No	204	54.5
Types of medications taken for diseases other than diabetes (n = 170)	ACEI	71	41.8
	Beta blockers	17	10.0
	NSAIDs	88	51.8
	Omeprazole	33	19.4
	Others *	99	26.5
Types of diseases for which other medications taken (n = 170)	Hypertension	119	70.0
	Heart failure	17	10.0
	Gastritis	33	19.4
	HIV/AIDS	13	7.6
	Others**	56	14.9
Neuropathy	Yes	235	62.8
	No	139	37.2
Retinopathy	Yes	169	45.2
	No	205	54.8
Nephropathy	Yes	164	43.9
	No	210	56.1
Macro-vascular complications	Yes	33	8.8
	No	341	91.2
History of hypertension	Yes	137	36.6
	No	237	63.4
Ever tested for HIV/AIDS	Yes	350	93.6
	No	24	6.4
HIV status of the patient (n = 350)	Positive	12	3.4
	Negative	338	96.6
History of blood loss	Yes	15	4.0
	No	359	96.0
Glycemic control	Good	143	38.2
	Poor	231	61.8
Systolic blood pressure (mmHg)	<140	270	72.2
	≥140	104	27.8
Diastolic blood pressure (mmHg)	<90	330	88.2
	≥90	44	11.8

NSAIDs: Non-steroidal Anti-inflammatory Drugs

* amoxicillin, ciprofloxacin, neurobion, nifidipine, hydrochlorothiazide, atorvastatin and Tenofovir/Lamivudine/Efavirenz

** peripheral neuropathy, urinary tract infections, blood loss and pneumonia